Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis

被引:178
作者
Zee, RYL
Ridker, PM
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol Cardiovasc Disor, Boston, MA 02215 USA
关键词
C-reactive protein; inflammation; genetics; risk factors; thrombosis;
D O I
10.1016/S0021-9150(01)00703-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While increased concentrations of C-reactive protein (CRP) are associated with increased vascular risk, little information is available describing genetic determinants of this effect. In a large prospective cohort of apparently healthy men, we found plasma CRP concentrations to be significantly reduced among carriers of a 1059G/C polymorphism in the human CRP gene (GC or CC) as compared with non-carriers (GG). However, the polymorphism examined was not significantly associated with risk of arterial thrombosis despite the fact that CRP concentrations are a potent independent predictor of future vascular events in this cohort. These data suggest that genetic and environmental determinants each importantly contribute to the vascular risk associated with inflammation. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:217 / 219
页数:3
相关论文
共 7 条
  • [1] Human C-reactive protein (CRP) 1059G/C polymorphism
    Cao, HN
    Hegele, RA
    [J]. JOURNAL OF HUMAN GENETICS, 2000, 45 (02) : 100 - 101
  • [2] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
    Danesh, J
    Whincup, P
    Walker, M
    Lennon, L
    Thomson, A
    Appleby, P
    Gallimore, JR
    Pepys, MB
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255): : 199 - 204
  • [3] Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5
  • [4] Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.
    Lindahl, B
    Toss, H
    Siegbahn, A
    Venge, P
    Wallentin, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) : 1139 - 1147
  • [5] Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study
    Pankow, JS
    Folsom, AR
    Cushman, M
    Borecki, IB
    Hopkins, PN
    Eckfeldt, JH
    Tracy, RP
    [J]. ATHEROSCLEROSIS, 2001, 154 (03) : 681 - 689
  • [6] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    Ridker, PM
    Cushman, M
    Stampfer, MJ
    Tracy, RP
    Hennekens, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) : 973 - 979
  • [7] C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    Ridker, PM
    Hennekens, CH
    Buring, JE
    Rifai, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) : 836 - 843